Cardiomegaly: Clinical Trials

438 trials for Cardiomegaly, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

210 completed, 90 unknown, 65 recruiting, 30 terminated. 93 Not applicable, 73 Phase 2, 48 Phase 4, 42 Phase 3, 30 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable93Completed 45, Unknown 16, Recruiting 8, Terminated 7, Active not recruiting 6, Not yet recruiting 4, Withdrawn 4, Suspended 2, Enrolling by invitation 1
Phase 273Completed 42, Recruiting 11, Unknown 9, Terminated 4, Withdrawn 4, Active not recruiting 2, Suspended 1
Phase 448Completed 34, Unknown 6, Terminated 4, Recruiting 2, Not yet recruiting 1, Withdrawn 1
Phase 342Completed 22, Unknown 10, Terminated 7, Recruiting 2, Withdrawn 1
Phase 130Recruiting 10, Completed 8, Terminated 5, Unknown 5, Suspended 1, Withdrawn 1
Early Phase 12Recruiting 1, Unknown 1

Follow Cardiomegaly: new trials by email Literature Review of Cardiomegaly trials Research Report on Cardiomegaly

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
BAG3-DCM Natural History Study
Dilated Cardiomyopathy (DCM), Cardiovascular Diseases
Not yet recruitingRocket Pharmaceuticals Inc.302026-12-012026-10-19
Therapeutic Implications of CMR Low Native T1 in Non-treated Non-hypertrophic Females With Fabry Disease (FD)
Decision tree for initiating treatment - Fabry Disease
Not applicableNot yet recruitingUniversity Hospital, Bordeaux602026-11-012026-10-14
An AAV Gene Therapy Trial of AFTX-201 in Adults With BAG3-Associated Dilated Cardiomyopathy (DCM)
AFTX-201 - Dilated Cardiomyopathy (DCM), BAG3 Mutation Associated Dilated Cardiomyopathy
Phase 1 / Phase 2RecruitingAffinia Therapeutics222026-10-012026-10-21
Detection of Cardiac Amyloidosis Using Right Ventricular Sensing Amplitude in Patients With Left Ventricular Hypertrophy
Cardiac amyloidosis screening during CIED implantation - Cardiac Amyloidosis, Left Ventricular Hypertrophy
Not applicableNot yet recruitingAssistance Publique - Hôpitaux de Paris2422026-09-012026-07-29
Can Exercise Electrocardiography Discriminate Hypertensive Heart Disease From Obstructive Coronary Artery Disease? A Multimodality Imaging Study
Obstructive Coronary Artery Disease, Left Ventricular Hypertrophy
RecruitingUniversity of Pisa302026-09-012026-09-29
Observational Study of Natural History of BAG3 Gene Mutation-Associated Dilated Cardiomyopathy in Chinese Adults
Observational, None intervention - Dilated Cardiomyopathy
RecruitingAstraZeneca102026-08-182026-10-22
Angiotensin Receptor Blocker After TAVR in Severe Aortic Stenosis With Left Ventricular Hypertrophy (ARBITAR)
Angiotensin Receptor Blocker (ARB) - Transcatheter Aortic Valve Replacement (TAVR), Left Ventricular Hypertrophy
Phase 4Not yet recruitingSeoul National University Hospital6322026-08-152026-07-29
AI-based Echocardiography for Detection of Cardiac Amyloidosis
AI-based echocardiogram - Cardiac Amyloidosis, Heart Failure With Preserved Ejection Fraction (HFPEF)
Not applicableNot yet recruitingGermans Trias i Pujol Hospital2002026-07-012026-06-12
Study of LX2006 Gene Therapy in Friedreich Ataxia Cardiomyopathy
LX2006, Usual Care - Friedreich Ataxia, Cardiomyopathy, Secondary
Phase 2RecruitingLexeo Therapeutics262026-06-252026-09-02
RHYthm and Myocardial Function Relationship Evaluation in Heart Diseases
speckle tracking echocardiography - Arrhythmia, Cardiomyopathy, Dilated
RecruitingFondazione Policlinico Universitario Agostino Gemelli IRCCS2532026-06-232026-09-10
A Study With NVC-001 in Patients With LMNA-related Dilated Cardiomyopathy (SUNBEAM-LMNA)
NVC-001 - Low Dose, NVC-001 - Intermediate Dose, NVC-001 - High Dose - LMNA-Related Dilated Cardiomyopathy
Phase 1 / Phase 2RecruitingNuevocor Pte. Ltd.212026-06-162026-08-07
Safety and Efficacy of Second Infusion of FAP iCDC in End-stage Dilated Cardiomyopathy
FAP immunosuppressive CAR-DC - Dilated Cardiomyopathy (DCM), Heart Failure
Phase 1RecruitingSecond Affiliated Hospital, Zhejiang University, School of Medicine52026-05-112026-07-02
Effect of Sildenafil on Left Ventricular Function in Pediatric With Primary Dilated Cardiomyopathy
Cardiomyopathy, Dilated
Not yet recruitingAssiut University702026-05-102026-04-17
A Phase 1 AAV Gene Therapy Trial Evaluating Safety and Preliminary Efficacy of RP-A701 in Subjects With BAG3 Dilated Cardiomyopathy
RP-A701 is a recombinant viral vector composed of an AAV serotype rh.74 (AAVrh.74) capsid encapsulating the transgene, BCL2-associated Athanogene 3 (BAG3) - Dilated Cardiomyopathy (DCM)
Phase 1RecruitingRocket Pharmaceuticals Inc.82026-04-172026-10-01
Mainstreaming Genetic Testing for Non-Ischemic Cardiomyopathy in Western Canada
Health service delivery change - Nonischemic Cardiomyopathy, Dilated Cardiomyopathy (DCM)
Not applicableEnrolling by invitationThomas Roston3002026-02-022026-05-08
Endocardial Delivery for Myocardial Regeneration Using Allogeneic iPSC-derived Cardiomyocyte Spheroids for HF With Systolic Dysfunction (EMERALD Study)
HS-005 - Heart Failure, Ischemic Heart Failure
Phase 1 / Phase 2RecruitingHeartseed Inc.142026-01-192026-10-22
Left Ventricular Hypertrophy in CKD Patients
transthoracic echocardiography - Left Ventricular Hypertrophy
Not yet recruitingSohag University1002026-01-152026-02-02
Prognostic Values of Coronary Microvascular Dysfunction in Patients With Dilated Cardiomyopathy
coronary angiography - Dilated Cardiomyopathy (DCM)
RecruitingSecond Affiliated Hospital, Zhejiang University, School of Medicine3302026-01-062025-12-19
Evaluation of the Efficacy of Diagnostic Support Algorithms in Chest X-rays- LuAna Trial
App LuAna - Consolidation, Lung Injury
Not applicableRecruitingHospital Israelita Albert Einstein24002026-01-052026-09-16
A Study of AZD4063 in PLN R14del Dilated Cardiomyopathy
AZD4063 - Dilated Cardiomyopathy
Phase 1RecruitingAstraZeneca232025-12-012026-09-04

Showing 20 of 438. Sign in to see all of them.

Narrower conditions

Cardiomyopathy, Dilated (242)  ·  Hypertrophy, Left Ventricular (162)  ·  Heart Failure (116)  ·  Cardiomyopathy, Hypertrophic (57)  ·  Hypertension (53)  ·  Cardiomyopathies (49)  ·  Cardiovascular Diseases (30)  ·  Heart Diseases (22)  ·  Aortic Valve Stenosis (19)  ·  Cardiomyopathy, Restrictive (14)  ·  Death, Sudden, Cardiac (14)  ·  Kidney Failure, Chronic (14)  ·  Arrhythmogenic Right Ventricular Dysplasia (13)  ·  Myocardial Infarction (13)

Broader conditions

Heart Diseases (416)  ·  Cardiovascular Diseases (408)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (270)  ·  Genetic Diseases, Inborn (258)  ·  Pathological Conditions, Signs and Symptoms (244)  ·  Laminopathies (238)  ·  Cardiomyopathies (226)  ·  Pathological Conditions, Anatomical (204)  ·  Hypertrophy (185)  ·  Vascular Diseases (109)  ·  Pathologic Processes (85)  ·  Heart Valve Diseases (77)  ·  Aortic Valve Disease (75)  ·  Aortic Stenosis, Subvalvular (57)

Interventions

Valsartan (10)  ·  Blood Specimen Collection (6)  ·  Allopurinol (5)  ·  Amlodipine (5)  ·  Echocardiography (5)  ·  Eplerenone (5)  ·  Losartan (5)  ·  dapagliflozin (5)  ·  Standard of Care (4)  ·  Tadalafil (4)  ·  paricalcitol (4)  ·  ARRY-371797 (3)  ·  Adrenergic beta-Antagonists (3)  ·  Atenolol (3)  ·  Cardiac Resynchronization Therapy (3)

Sponsors

National Heart, Lung, and Blood Institute (NHLBI) (13)  ·  Imperial College London (9)  ·  University Medical Centre Ljubljana (6)  ·  AstraZeneca (5)  ·  Johns Hopkins University (5)  ·  University Hospital, Bordeaux (5)  ·  Assistance Publique - Hôpitaux de Paris (4)  ·  Assiut University (4)  ·  LoneStar Heart, Inc. (4)  ·  Massachusetts General Hospital (4)  ·  McGill University Health Centre/Research Institute of the McGill University Health Centre (4)  ·  Novartis Pharmaceuticals (4)  ·  Second Affiliated Hospital, Zhejiang University, School of Medicine (4)  ·  University of Colorado, Denver (4)  ·  University of Dundee (4)

Countries

United States (111)  ·  United Kingdom (46)  ·  Germany (38)  ·  China (36)  ·  France (36)  ·  Italy (30)  ·  Canada (26)  ·  Spain (21)  ·  Denmark (16)  ·  Poland (16)  ·  Netherlands (14)  ·  Brazil (12)  ·  Sweden (11)  ·  Turkey (Türkiye) (11)  ·  Belgium (10)

Top investigators

Ercan Ok, MD (3)  ·  James Ware (3)  ·  Andrew M South, MD MS (2)  ·  Andrew T Yan, MD (2)  ·  Barry Greenberg, MD (2)  ·  Bojan Vrtovec, MD, PhD (2)  ·  Elisa Giannetta, MD - Phd (2)  ·  Franz Schaefer, MD (2)  ·  Ida Jovanovic, Prof,MD,PhD (2)  ·  Javier Bermejo Thomas, MD, PhD (2)  ·  Jianjun Mu, doctor (2)

Results publications

PMID 36718638, PMID 38979608, PMID 17582361, PMID 18591942, PMID 22651868, PMID 22936827, PMID 23362308, PMID 24414062, PMID 25142002, PMID 26680013, PMID 28917683, PMID 37010012, PMID 42669063, PMID 10028970, PMID 10030657, PMID 10199738, PMID 10213344, PMID 10368877, PMID 10450601, PMID 10556226, PMID 10594802, PMID 10598732, PMID 10678860, PMID 10802712, PMID 10830164, PMID 10908222, PMID 10940788, PMID 10952828, PMID 11055975, PMID 11057898, PMID 11208620, PMID 11250334, PMID 11403367, PMID 11422885, PMID 11514367, PMID 11710893, PMID 11803349, PMID 12088775, PMID 12106931, PMID 12172314, PMID 12356407, PMID 12423712, PMID 12457625, PMID 12555153, PMID 12652219, PMID 12668503, PMID 12714020, PMID 12738602, PMID 12742978, PMID 12906982

NIH funding

2015 (4), 2019 (3), 2009 (2), 2014 (2), 2017 (2), 2025 (2), R01DK062030 (2), 2004 (1), 2008 (1), 2016 (1), 2018 (1), K23HL071562 (1), K23HL078901 (1), K23HL119622 (1), K23HL148394 (1)